Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|April 2, 2024
The PRC2.1 Subcomplex Opposes G1 Progression through Regulation of CCND1 and CCND2Adam D Longhurst, Kyle Wang, Harsha Garadi Suresh, et al.
Surgical Neurology International|June 3, 2026
Predictive capacity of mismatch repair status in the use of immune checkpoint inhibitors for the treatment of aggressive pituitary tumors and pituitary carcinomas: An illustrative case report and literature reviewNatalie Ivey, Jeff F Zhang, Abigail Zack, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional AnalysisVivek Verma, Valerie K Shostrom, Weining Zhen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2018
Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell CaptureJa Hye Myung, Michael J Eblan, Joseph M Caster, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 28, 2023
Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapyJacob Hall, Kevin Lui, Xianming Tan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 9, 2020
Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate CancerTrevor J Royce, Panayiotis Mavroidis, Kyle Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2018
Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified ChemoradiotherapyKevin A Pearlstein, Kyle Wang, Robert J Amdur, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 21, 2017
Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancerKyle Wang, Kevin A Pearlstein, Nicholas D Patchett, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2021
Coronary Artery Calcifications and Cardiac Risk After Radiation Therapy for Stage III Lung CancerKyle Wang, Hayley E Malkin, Nicholas D Patchett, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
GABA(A) receptor activation drives GABARAP-Nix mediated autophagy to radiation-sensitize primary and brain-metastatic lung adenocarcinoma tumorsDebanjan Bhattacharya, Riccardo Barille, Donatien Kamdem Toukam, et al.
Pageof 6